FOI release

Freedom of Information responses from the MHRA - week commencing 1 March 2021

Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 1 March 2021

• From: Medicines and Healthcare products Regulatory Agency
• Published: 28 April 2021

Documents

Freedom of Information request on adverse reactions to COVID-19 vaccines (FOI 21-065)

HTML

Freedom of Information request on adverse reactions to COVID-19 vaccines data (FOI 21-111)

HTML

Freedom of Information request on adverse reactions to to the human papillomavirus (HPV) vaccination (FOI 21-112)

HTML

Freedom of Information request on adverse reactions to to the human papillomavirus (HPV) vaccination (FOI 21-112)

PDF, 101 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 1 (FOI-21-112)

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 2 (FOI-21-112)

PDF, 30 KB, 20 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about adverse drug reactions (ADR) to COVID-19 vaccines (FOI-21-113)

HTML

Freedom of Information request about adverse drug reactions (ADR) to COVID-19 vaccines (FOI-21-115)

HTML

Freedom of Information request about the safety of COVID-19 vaccines (FOI-21-124)

HTML

Freedom of Information request for the number of times Ethigen have been reported/investigated by MHRA (FOI-21-133)

HTML

Freedom of Information request for a redacted version of the final inspection report for the GCP inspection: INSP GCP 41062/5808009-0002 (FOI-21-137)

HTML

Freedom of Information request about adverse drug reactions (ADR) to COVID-19 vaccines (FOI 21-143)

HTML

Freedom of Information request about adverse drug reactions (ADR) to COVID-19 vaccines (FOI 21-147)

HTML

Freedom of Information request about a 'Russian vaccine' (FOI 21-172)

HTML

Freedom of Information request about clinical trials on tricyclic antidepressants submitted to the UK (FOI 21-179)

HTML

Freedom of Information request about the safety of the COVID-19 vaccines (FOI 21-186)

HTML

Freedom of Information request about the safety of the COVID-19 vaccines (FOI 21-186)

PDF, 126 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about the safety of the COVID-19 vaccines (FOI 21-199)

HTML

Freedom of Information request about the status of any MA application for sacituzumab (FOI 21-200)

HTML

Freedom of Information request about Yellow Card reports for childhood vaccines (FOI 21-210)

HTML

Freedom of Information request about Yellow Card reports for childhood vaccines (FOI 21-210)

PDF, 103 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 1 (FOI 21-210)

PDF, 70.3 KB, 37 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 2 (FOI 21-210)

PDF, 51.8 KB, 29 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 3 (FOI 21-210)

PDF, 72.3 KB, 38 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 4 (FOI 21-210)

PDF, 105 KB, 49 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 8 (FOI 21-210)

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 10 (FOI 21-210)

PDF, 42 KB, 25 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about deaths directly caused by COVID-19 (FOI 21-211)

HTML

Freedom of Information request about deaths directly caused by COVID-19 (FOI 21-211)

PDF, 89.2 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request (FOI 21-212)

HTML

Freedom of Information request about adverse drug reactions (ADR) to COVID-19 vaccines (FOI 21-216)

HTML

Details

See the MHRA FOI disclosure log.

See all FOI responses from the MHRA for 2021.

Published 28 April 2021